TWD 18.6
(-0.53%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.67 Billion | -659.72 Million | -1.14 Billion | 289.18 Million | 98.3 Million | -1.06 Billion |
Net Income | 683.72 Million | 190.16 Million | 55.11 Million | 166.48 Million | 247.85 Million | 163.88 Million |
Depreciation & Amortization | 32.05 Million | 33.8 Million | 34.9 Million | 33.66 Million | 31.73 Million | 27.29 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.02 Billion | -792.53 Million | -1.15 Billion | 166.59 Million | -60.07 Million | -1.17 Billion |
Other non-cash items | -67.84 Million | -91.16 Million | -83.82 Million | -77.56 Million | -121.2 Million | -89.83 Million |
Investing Cash Flow | -53.7 Million | 278 Thousand | 1.97 Million | -231 Thousand | 41 Million | 26.21 Million |
Investments in PPE | -375 Thousand | -1.79 Million | - | -2.49 Million | -889 Thousand | -295 Thousand |
Acquisitions | -53.33 Million | -3.38 Million | -15.13 Million | -15.19 Million | 1.75 Million | 25.54 Million |
Investment purchases | - | - | - | -307 Thousand | 59 Thousand | -1.9 Million |
Sales/Maturities of investments | - | - | 70 Thousand | 15.19 Million | 78.23 Million | 26.85 Million |
Other Investing Activities | -48.93 Million | 5.46 Million | 17.04 Million | 2.57 Million | -38.14 Million | 968 Thousand |
Financing Cash Flow | -1.1 Billion | 668.65 Million | 1.41 Billion | -413.4 Million | -302.77 Million | 474.92 Million |
Debt repayment | -926.93 Million | -2.04 Billion | -1.37 Billion | -2.68 Billion | -2.62 Billion | -3.01 Billion |
Dividends payments | -176.15 Million | - | - | -176.15 Million | -176.15 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.33 Million | 2.71 Billion | 2.79 Billion | 2.44 Billion | 2.49 Billion | 3.49 Billion |
Accounts receivables | -24.8 Million | 47.59 Million | 75.43 Million | -3.24 Million | 63.31 Million | 39.2 Million |
Accounts payables | 10.95 Million | -70.36 Million | 159.31 Million | -92.27 Million | -33.2 Million | 35.35 Million |
Inventory | 830.42 Million | -1.04 Billion | -1.88 Billion | 203.17 Million | -85.45 Million | -1.37 Billion |
Other working capital | 207.85 Million | 274.85 Million | 499.25 Million | 58.94 Million | -4.74 Million | 209.41 Million |
Cash at beginning of period | 510.9 Million | 495.21 Million | 221.92 Million | 346.22 Million | 510 Million | 1.08 Billion |
Cash at end of period | 1.08 Billion | 510.9 Million | 495.21 Million | 221.92 Million | 346.22 Million | 510 Million |
Capital Expenditure | -375 Thousand | -1.79 Million | - | -2.49 Million | -889 Thousand | -295 Thousand |
Effect of forex changes on cash | -8.99 Million | 6.47 Million | 1.62 Million | 162 Thousand | -318 Thousand | -2.87 Million |
Net cash flow / Change in cash | 578.45 Million | 15.68 Million | 273.29 Million | -124.29 Million | -163.78 Million | -570.69 Million |
Free Cash Flow | 1.67 Billion | -661.52 Million | -1.14 Billion | 286.68 Million | 97.41 Million | -1.06 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -42.99 Million | 155.36 Million | 683.72 Million | 296.68 Million | 461.97 Million | 1.7 Million |
Depreciation & Amortization | 8.15 Million | 8.01 Million | 32.05 Million | 8 Million | 7.79 Million | 7.88 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -225.31 Million | 282.32 Million | 1.02 Billion | 491.41 Million | 530.67 Million | -10.58 Million |
Other non-cash items | 362.41 Million | -370.24 Million | -67.84 Million | -55.25 Million | -33.46 Million | -45.67 Million |
Investing Cash Flow | -9.17 Million | -2.01 Million | -53.7 Million | -53.05 Million | 593 Thousand | -2.45 Million |
Investments in PPE | -1.42 Million | -456 Thousand | -375 Thousand | - | - | - |
Acquisitions | -7.75 Million | -1.55 Million | -53.33 Million | -53.05 Million | - | -282 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | -2.16 Million |
Other Investing Activities | -1.33 Million | - | -48.93 Million | -51.69 Million | 593 Thousand | - |
Financing Cash Flow | -63.25 Million | -230.13 Million | -1.1 Billion | -583.31 Million | -728.36 Million | 70.93 Million |
Debt repayment | -62.42 Million | -228.1 Million | -926.93 Million | -582.47 Million | -772.27 Million | -345.12 Million |
Dividends payments | - | - | -176.15 Million | - | -176.15 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -7.75 Million | -1.29 Million | -1.33 Million | -843 Thousand | 220.06 Million | 416.05 Million |
Accounts receivables | -7.14 Million | 71.42 Million | -24.8 Million | -45.03 Million | 14.12 Million | -23.79 Million |
Accounts payables | 223.58 Million | -55.02 Million | 10.95 Million | -4.72 Million | 8.23 Million | -39.19 Million |
Inventory | -582.9 Million | 383.56 Million | 830.42 Million | 540.77 Million | 566.71 Million | -191.52 Million |
Other working capital | 141.15 Million | -117.64 Million | 207.85 Million | 402 Thousand | -58.4 Million | 243.94 Million |
Cash at beginning of period | 1.19 Billion | 1.08 Billion | 510.9 Million | 899.89 Million | 650.74 Million | 636.6 Million |
Cash at end of period | 849.54 Million | 1.19 Billion | 1.08 Billion | 1.08 Billion | 899.89 Million | 650.74 Million |
Capital Expenditure | -1.42 Million | -456 Thousand | -375 Thousand | - | - | - |
Effect of forex changes on cash | - | - | -8.99 Million | -8.17 Million | 9.93 Million | -10.12 Million |
Net cash flow / Change in cash | -347.32 Million | 107.5 Million | 578.45 Million | 189.46 Million | 249.15 Million | 14.14 Million |
Free Cash Flow | -281.94 Million | 458.93 Million | 1.67 Billion | 740.84 Million | 966.98 Million | -46.66 Million |
ZWIPE
SCLP
9031
688070
BIOFILCHEM
LEOF